Is Atropine an Anticholinergic? Uses and Effects

Yes, atropine is an anticholinergic drug. More specifically, it is an antimuscarinic, meaning it blocks a particular subset of receptors that the chemical messenger acetylcholine normally activates. This distinction matters because “anticholinergic” is a broad category, and atropine targets only the muscarinic type of acetylcholine receptor, not the nicotinic type. That selective blocking action is what makes atropine useful across a surprisingly wide range of medical situations, from slowing a racing gut before surgery to counteracting nerve agent poisoning.

How Atropine Works at the Receptor Level

Your nervous system uses acetylcholine to control many automatic body functions: heart rate, digestion, saliva production, pupil size, and airway diameter. Atropine competes with acetylcholine for the same docking sites on cells, called muscarinic receptors, and wins the parking spot without switching anything on. The result is that the “rest and digest” arm of your nervous system (the parasympathetic system) gets dialed down, and the “fight or flight” arm (the sympathetic system) effectively takes over by default.

This is why atropine speeds up the heart, dries out the mouth, relaxes the airways, and dilates the pupils. It is not stimulating anything directly. It is simply removing the brake that acetylcholine normally applies, letting the body’s built-in stimulatory signals dominate.

Where Atropine Comes From

Atropine is a naturally occurring alkaloid originally isolated from the plant Atropa belladonna (deadly nightshade) and related species in the Solanaceae family, including Datura stramonium (jimsonweed). The name “atropine” itself derives from Atropa belladonna. Today it is produced synthetically for medical use, but its chemical structure is identical to the compound found in the plant.

Common Medical Uses

Slow Heart Rate (Bradycardia)

When the heart beats dangerously slowly, atropine is often the first drug used. By blocking the vagus nerve’s slowing effect on the heart, it allows the heart rate to rise. The American Heart Association’s current protocol calls for a 1 mg intravenous dose, repeated every 3 to 5 minutes if needed, up to a maximum of 3 mg.

Organophosphate and Nerve Agent Poisoning

Organophosphate pesticides and chemical nerve agents work by flooding the body with acetylcholine, causing a crisis of excessive secretions, airway constriction, slowed heart rate, and muscle dysfunction. Atropine directly counters these effects. In poisoning cases, doctors use a doubling-dose strategy: an initial 1 to 3 mg bolus, then double the dose every five minutes until breathing improves and heart rate stabilizes above 80 beats per minute. The amounts needed can be far higher than in any other clinical situation.

Slowing Nearsightedness in Children

Low-dose atropine eye drops have become one of the most studied treatments for slowing myopia progression in children. Concentrations as low as 0.01% to 0.05% are used nightly. In the LAMP study, children receiving 0.05% atropine drops saw their nearsightedness worsen by only 0.27 diopters over a year, compared to 0.81 diopters in the placebo group. Even the lowest concentration tested, 0.01%, reduced the rate of eye elongation by about 12% compared to placebo. Higher concentrations like 1% can cut progression by roughly 77% over two years, but they come with more noticeable side effects like light sensitivity and difficulty focusing up close, so lower doses are generally preferred for long-term use.

Before Surgery

Atropine is sometimes given before general anesthesia to reduce saliva and airway secretions, which helps keep the breathing passage clear during the procedure. In children, the dose is weight-based, typically 0.01 to 0.02 mg per kilogram.

Eye Exams and Procedures

Ophthalmologists use atropine drops to dilate the pupil and relax the focusing muscle inside the eye. Because atropine’s effect on the pupil lasts much longer than shorter-acting dilating drops, it is reserved for specific diagnostic and therapeutic situations rather than routine exams.

Side Effects Reflect Its Anticholinergic Action

Nearly every side effect of atropine traces directly back to acetylcholine being blocked. The most common ones are dry mouth, blurred vision, sensitivity to light, rapid heart rate, flushing, and hot, dry skin. These are collectively known as “anticholinergic effects,” and they show up with any drug in this class, not just atropine.

Constipation, difficulty urinating, and an inability to sweat can also occur. Older adults are especially vulnerable to these effects because aging already reduces the body’s acetylcholine activity, so adding a drug that blocks it further can tip the balance. Confusion and agitation are possible at higher doses, particularly in elderly patients.

Who Should Avoid Atropine

People with narrow-angle glaucoma face a specific risk. Atropine dilates the pupil, which can push the iris forward and physically block the drainage channel for fluid inside the eye. This traps fluid, causes a rapid spike in eye pressure, and can trigger an acute glaucoma attack with sudden pain and vision loss. The same mechanism makes any anticholinergic drug risky for people with this eye anatomy.

Atropine can also worsen urinary retention in people with an enlarged prostate, because blocking acetylcholine relaxes the bladder muscle and makes it harder to empty. In conditions where gut motility is already dangerously slow, such as a bowel obstruction, further slowing things down with atropine would be harmful.

Atropine vs. Other Anticholinergics

Atropine is considered a nonselective muscarinic antagonist, meaning it blocks all five subtypes of muscarinic receptor throughout the body. This is why its effects are so widespread. Many newer anticholinergic drugs are designed to be more selective. Medications for overactive bladder, for instance, preferentially target the muscarinic receptors in bladder muscle, reducing (though not eliminating) side effects like dry mouth and blurred vision. Inhaled anticholinergics used for asthma or COPD are formulated to stay in the lungs and minimize systemic absorption.

Atropine’s lack of selectivity is actually an advantage in emergencies. When someone is poisoned with an organophosphate, you want every muscarinic receptor in the body blocked simultaneously. But for everyday chronic conditions, more targeted anticholinergics are typically a better fit.